References
- Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Immunol Today 1992; 13:136-42; PMID:1374612; https://doi.org/https://doi.org/10.1016/0167-5699(92)90111-J
- Liu J, Farmer JD, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991; 66:807-15; PMID:1715244; https://doi.org/https://doi.org/10.1016/0092-8674(91)90124-H
- Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357:2601-14; PMID:18094380; https://doi.org/https://doi.org/10.1056/NEJMra064928
- Neofytos D, Fishman JA, Horn D, Anaissie E, Chang CH, Olyaei A, Pfaller M, Steinbach WJ, Webster KM, Marr KA. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl Infect Dis 2010; 12:220-9; PMID:20113459; https://doi.org/https://doi.org/10.1111/j.1399-3062.2010.00492.x
- Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002; 100:4358-66; PMID:12393425; https://doi.org/https://doi.org/10.1182/blood-2002-05-1496
- Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34:909-17; PMID:11880955; https://doi.org/https://doi.org/10.1086/339202
- Singh G, Imai J, Clemons KV, Stevens DA. Efficacy of caspofungin against central nervous system Aspergillus fumigatus infection in mice determined by TaqMan PCR and CFU methods. Antimicrob Agents Chemother 2005; 49:1369-76; PMID:15793114; https://doi.org/https://doi.org/10.1128/AAC.49.4.1369-1376.2005
- John GT, Shankar V, Talaulikar G, Mathews MS, Abraham MA, Thomas PP, Jacob CK. Epidemiology of systemic mycoses among renal-transplant recipients in India. Transplantation 2003; 75:1544-51; PMID:12792512; https://doi.org/https://doi.org/10.1097/01.TP.0000061610.34110.04
- Paya CV. Fungal infections in solid-organ transplantation. Clin Infect Dis 1993; 16:677-88; PMID:8507760; https://doi.org/https://doi.org/10.1093/clind/16.5.677
- Dummer JS, Hardy A, Poorsattar A, Ho M. Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation 1983; 36:259-67; PMID:6310832; https://doi.org/https://doi.org/10.1097/00007890-198309000-00007
- Stewart AA, Ingebritsen TS, Manalan A, Klee CB, Cohen P. Discovery of A Ca2+-and calmodulin-dependent protein phosphatase. FEBS Letters 1982; 137:80-4; PMID:6279434; https://doi.org/https://doi.org/10.1016/0014-5793(82)80319-0
- Steinbach WJ, Reedy JL, Cramer RA, Perfect JR, Heitman J. Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections. Nat Rev Micro 2007; 5:418-30; https://doi.org/https://doi.org/10.1038/nrmicro1680
- Steinbach WJ, Cramer RA, Perfect BZ, Asfaw YG, Sauer TC, Najvar LK, Kirkpatrick WR, Patterson TF, Benjamin DK, Heitman J. Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatus. Eukaryotic Cell 2006; 5:1091-103; PMID:16835453; https://doi.org/https://doi.org/10.1128/EC.00139-06
- Imbert S, Bresler P, Boissonnas A, Gauthier L, Souchet L, Uzunov M, Leblond V, Mazier D, Nguyen S, Fekkar A. Calcineurin inhibitors impair neutrophil activity against Aspergillus fumigatus in allogeneic hematopoietic stem cell transplant recipients. J Allergy Clin Immunol 2016; 138:860-8; PMID:27132218; https://doi.org/https://doi.org/10.1016/j.jaci.2016.02.026
- High KP, Washburn RG. Invasive aspergillosis in mice immunosuppressed with cyclosporin A, tacrolimus (FK506), or sirolimus (rapamycin). J Infect Dis 1997; 175:222-5; PMID:8985226; https://doi.org/https://doi.org/10.1093/infdis/175.1.222
- Vecchiarelli A, Cenci E, Marconi P, Rossi R, Riccardi C, Bistoni F. Immunosuppressive effect of cyclosporin A on resistance to systemic infection with Candida albicans. J Med Microbiol 1989; 30:183-92; PMID:2511321; https://doi.org/https://doi.org/10.1099/00222615-30-3-183
- Greenblatt MB, Aliprantis A, Hu B, Glimcher LH. Calcineurin regulates innate antifungal immunity in neutrophils. J Exp Med 2010; 207:923-31; PMID:20421389; https://doi.org/https://doi.org/10.1084/jem.20092531
- Herbst S, Shah A, Mazon Moya M, Marzola V, Jensen B, Reed A, Birrell MA, Saijo S, Mostowy S, Shaunak S, et al. Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus. EMBO Mol Med 2015; 7:240-58; PMID:25637383; https://doi.org/https://doi.org/10.15252/emmm.201404556
- Krause MW, Schaffner A. Comparison of immunosuppressive effects of cyclosporine A in a murine model of systemic candidiasis and of localized thrushlike lesions. Infect Immun 1989; 57:3472-8; PMID:2807532
- Ito E, Tanaka Y. Influences of immunosuppressive agents, FK506 and cyclosporin on systemic Candida albicans infection in mice. Mycopathologia 1997; 138:57-64; PMID:9433807; https://doi.org/https://doi.org/10.1023/A:1006827828838
- Mody CH, Toews GB, Lipscomb MF. Treatment of murine cryptococcosis with cyclosporin-A in normal and athymic mice. Ann Arbor 1989; 1001:48109-0360
- Mody C, Toews G, Lipscomb M. Cyclosporin A inhibits the growth of Cryptococcus neoformans in a murine model. Infect Immun 1988; 56:7-12; PMID:3275587
- Dreyfuss M, Härri E, Hofmann Hea, Kobel H, Pache W, Tscherter H. Cyclosporin A and C. Eur J Applied Microbiol Biotechnol 1976; 3:125-33; https://doi.org/https://doi.org/10.1007/BF00928431
- Cohen D, Loertscher R, Rubin M, Tilney N, Carpenter C, Strom T. Cyclosporine: a new immunosuppressive agent for organ transplantation. Annals Internal Med 1984; 101:667-82; PMID:6385799; https://doi.org/https://doi.org/10.7326/0003-4819-101-5-667
- Bader T, Bodendorfer B, Schröppel K, Morschhäuser J. Calcineurin is essential for virulence in Candida albicans. Infect Immun 2003; 71:5344-54; PMID:12933882; https://doi.org/https://doi.org/10.1128/IAI.71.9.5344-5354.2003
- Odom A, Muir S, Lim E, Toffaletti DL, Perfect J, Heitman J. Calcineurin is required for virulence of Cryptococcus neoformans. EMBO J 1997; 16:2576-89; PMID:9184205; https://doi.org/https://doi.org/10.1093/emboj/16.10.2576
- Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 2007; 44:531-40; PMID:17243056; https://doi.org/https://doi.org/10.1086/510592
- Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev 2005; 18:44-69; PMID:15653818; https://doi.org/https://doi.org/10.1128/CMR.18.1.44-69.2005
- Kim JH, Perfect JR. Infection and cyclosporine. Rev Infect Dis 1989; 11:677-90; PMID:2682942; https://doi.org/https://doi.org/10.1093/clinids/11.5.677
- Borghi E, Morace G, Borgo F, Rajendran R, Sherry L, Nile C, Ramage G. New strategic insights into managing fungal biofilms. Frontiers Microbiol 2015; 6:1077; PMID:26500623; https://doi.org/https://doi.org/10.3389/fmicb.2015.01077
- Clancy CJ, Jaber RA, Leather HL, Wingard JR, Staley B, Wheat LJ, Cline CL, Rand KH, Schain D, Baz M, et al. Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients. J Clin Microbiol 2007; 45:1759-65; PMID:17428933; https://doi.org/https://doi.org/10.1128/JCM.00077-07
- Steinbach WJ, Schell WA, Blankenship JR, Onyewu C, Heitman J, Perfect JR. In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus. Antimicrob Agents Chemother 2004; 48:1664-9; PMID:15105118; https://doi.org/https://doi.org/10.1128/AAC.48.5.1664-1669.2004
- Chaturvedi PR, Decker CJ, Odinecs A. Prediction of pharmacokinetic properties using experimental approaches during early drug discovery. Curr Opin Chem Biol 2001; 5:452-63; PMID:11470610; https://doi.org/https://doi.org/10.1016/S1367-5931(00)00228-3
- Huyan XH, Lin YP, Gao T, Chen RY, Fan YM. Immunosuppressive effect of cyclophosphamide on white blood cells and lymphocyte subpopulations from peripheral blood of Balb/c mice. Int Immunopharmacol 2011; 11:1293-7; PMID:21530682; https://doi.org/https://doi.org/10.1016/j.intimp.2011.04.011
- Lewis RE, Wiederhold NP. Murine model of invasive aspergillosis. Antifungal Agents: Methods Protocols 2005; 118:129-42
- Romani L. Immunity to fungal infections. Nat Rev Immunol 2004; 4:1-23; PMID:14661066; https://doi.org/https://doi.org/10.1038/nri1255
- Mircescu MM, Lipuma L, van Rooijen N, Pamer EG, Hohl TM. Essential role for neutrophils but not alveolar macrophages at early time points following Aspergillus fumigatus infection. J Infect Dis 2009; 200:647-56; PMID:19591573; https://doi.org/https://doi.org/10.1086/600380
- Ibrahim-Granet O, Jouvion G, Hohl T, Droin-Bergere S, Philippart F, Kim O, Adib-Conquy M, Schwendener R, Cavaillon JM, Brock M. In vivo bioluminescence imaging and histopathopathologic analysis reveal distinct roles for resident and recruited immune effector cells in defense against invasive aspergillosis. BMC Microbiol 2010; 10:105; PMID:20377900; https://doi.org/https://doi.org/10.1186/1471-2180-10-105
- Janco RL, English D. Cyclosporine and human neutrophil function. Transplantation 1983; 35:501-3; PMID:6302959; https://doi.org/https://doi.org/10.1097/00007890-198305000-00023
- Roilides E, Robinson T, Sein T, Pizzo PA, Walsh TJ. In vitro and ex vivo effects of cyclosporin A on phagocytic host defenses against Aspergillus fumigatus. Antimicrob Agents Chemother 1994; 38:2883-8; PMID:7695277; https://doi.org/https://doi.org/10.1128/AAC.38.12.2883
- Marchetti O, Moreillon P, Glauser MP, Bille J, Sanglard D. Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans. Antimicrob Agents Chemother 2000; 44:2373-81; PMID:10952582; https://doi.org/https://doi.org/10.1128/AAC.44.9.2373-2381.2000
- Morgenstern DE, Gifford MA, Li LL, Doerschuk CM, Dinauer MC. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J Exp Med 1997; 185:207-18; PMID:9016870; https://doi.org/https://doi.org/10.1084/jem.185.2.207
- Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 2001; 107:135-42; PMID:11160126; https://doi.org/https://doi.org/10.1172/JCI11914
- Balloy V, Huerre M, Latgé J-P, Chignard M. Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis. Infect Immunity 2005; 73:494-503; PMID:15618189; https://doi.org/https://doi.org/10.1128/IAI.73.1.494-503.2005
- Galiger C, Brock M, Jouvion G, Savers A, Parlato M, Ibrahim-Granet O. Assessment of efficacy of antifungals against Aspergillus fumigatus: value of real-time bioluminescence imaging. Antimicrob Agents Chemother 2013; 57:3046-59; PMID:23587947; https://doi.org/https://doi.org/10.1128/AAC.01660-12
- Brock M, Jouvion G, Droin-Bergere S, Dussurget O, Nicola MA, Ibrahim-Granet O. Bioluminescent Aspergillus fumigatus, a new tool for drug efficiency testing and in vivo monitoring of invasive aspergillosis. Applied Environmental Microbiol 2008; 74:7023-35; PMID:18820063; https://doi.org/https://doi.org/10.1128/AEM.01288-08
- Laskaris P, Atrouni A, Calera JA, d'Enfert C, Munier-Lehmann H, Cavaillon JM, Latgé JP, Ibrahim-Granet O. Administration of zinc chelators improves survival of mice infected with Aspergillus fumigatus both in monotherapy and in combination with caspofungin. Antimicrob Agents Chemother 2016; 60:5631-9; PMID:27401578; https://doi.org/https://doi.org/10.1128/AAC.00324-16